Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine.
about
Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in miceImproved Efficacy of a Gene Optimised Adenovirus-based Vaccine for Venezuelan Equine Encephalitis VirusPrinciples of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agentsVaccination of rabbits with an alkylated toxoid rapidly elicits potent neutralizing antibodies against botulinum neurotoxin serotype B.What next for botulism vaccine development?Botulinum toxin: bioweapon & magic drugImmunization of mice with the non-toxic HC50 domain of botulinum neurotoxin presented by rabies virus particles induces a strong immune response affording protection against high-dose botulinum neurotoxin challenge.Intranasal vaccination with an engineered influenza virus expressing the receptor binding subdomain of botulinum neurotoxin provides protective immunity against botulism and influenza.Sublingual immunization with adenovirus F protein-based vaccines stimulates protective immunity against botulinum neurotoxin A intoxication.Protective immunity against tularemia provided by an adenovirus-vectored vaccine expressing Tul4 of Francisella tularensis.Adenovirus Specific Pre-Immunity Induced by Natural Route of Infection Does Not Impair Transduction by Adenoviral Vaccine Vectors in Mice.Oral vaccination with an adenovirus-vectored vaccine protects against botulism.Enhanced induction of intestinal cellular immunity by oral priming with enteric adenovirus 41 vectors.Technical transformation of biodefense vaccines.Induction of protective neutralizing antibody responses against botulinum neurotoxin serotype C using plasmid carried by PLGA nanoparticlesDNA electroporation in rabbits as a method for generation of high-titer neutralizing antisera: examples of the botulinum toxins types A, B, and EAdenovirus-vectored vaccines.Vaccines against Botulism.Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus.Dual-route targeted vaccine protects efficiently against botulinum neurotoxin A complex.
P2860
Q21092172-7FAA8CB9-CE6D-4ACF-9615-6D3B0FB71935Q27489413-9AB54C0E-E186-4CF8-9E4F-D3C4427B76E8Q28384852-94DEDAEB-45A2-404A-94FD-19B82DE75B70Q33909140-87C85871-1B7F-46E9-93DA-D0A9420341E1Q34343808-930A6189-E0C5-4D62-86EB-714E647864CDQ34530009-9178ACA1-0CEC-4857-B2C5-5AE5F40F3110Q35043107-8535C491-EF28-4C67-8B8E-A569EC01F5E6Q35507796-277F50A6-7D26-4570-99E7-B408C18E2A3DQ35722157-98F311BE-9051-4F8D-B012-319DE29C4898Q35805265-CBA319CE-450C-4791-AA08-74AFFC706932Q35871976-2609BC28-D60F-4906-9F13-AD3C3D0D6465Q36734902-B05E39F7-6161-4E6E-A46A-DDD8074E726DQ37033283-E15DBBC4-7B3E-4B9B-9DF4-D886C7E47C39Q37058898-AF93E91B-6F44-4B90-A67D-A5FEC66D7083Q37130982-669F3FD8-2D24-4E63-8392-56EC666DC579Q37530489-D21C75C9-4052-4EA2-A1EE-A88E618B4B57Q37689799-94674095-F52F-4F8D-8384-67118AF834C0Q40059125-59591F6C-CEEE-4D8F-BDEB-147242277B33Q41242033-63427A05-0B12-4117-9A96-79D48A315B80Q47359574-93D9EE2D-1A36-4B7F-B2A2-FE3FFEAB39F0
P2860
Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Protective immunity against bo ...... n adenovirus-vectored vaccine.
@ast
Protective immunity against bo ...... n adenovirus-vectored vaccine.
@en
type
label
Protective immunity against bo ...... n adenovirus-vectored vaccine.
@ast
Protective immunity against bo ...... n adenovirus-vectored vaccine.
@en
prefLabel
Protective immunity against bo ...... n adenovirus-vectored vaccine.
@ast
Protective immunity against bo ...... n adenovirus-vectored vaccine.
@en
P2093
P2860
P1433
P1476
Protective immunity against bo ...... n adenovirus-vectored vaccine.
@en
P2093
Lance L Simpson
Leonard A Smith
Michael E Pichichero
Mingtao Zeng
P2860
P304
P356
10.1016/J.VACCINE.2007.08.035
P407
P577
2007-09-05T00:00:00Z